AUREALIS PHARMA
Aurealis Pharma is a biopharmaceutical company aiming at developing ground-breaking medicines for the treatment of cancer and chronic wounds. They are dedicated in the R&D of gene and cell based therapies, as well as the development of new active molecules by computational modeling of nature derived compounds. Their key strategy is to perform outstanding interdisciplinary R&D and to implement these into new business models. They are actively seeking for collaborations with pharmaceutical companies, academic research institutions and pre-clinical CROs.
AUREALIS PHARMA
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2010-04-01
Address:
Kuopio, Eastern Finland, Finland
Country:
Finland
Website Url:
http://www.aurealispharma.com
Total Employee:
1+
Status:
Active
Contact:
+358458433550
Total Funding:
13.4 M CHF
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Fastly Hosted Fastly Load Balancer Hover
Similar Organizations
Acasti Pharma
Acasti Pharma is an emerging biopharmaceutical company.
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Fosun Pharma
Fosun Pharma is a pharmaceutical company.
IntraBio
IntraBio is a biopharmaceutical company.
Jamjoom Pharma
Jamjoom Pharma is pharmaceutical company
Molecular Partners
Molecular Partners is a clinical-stage biopharmaceutical company.
Newron Pharmaceuticals
Newron Pharmaceuticals S.p.A. is a biopharmaceutical company
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Swedish Orphan Biovitrum
International Pharmaceutical Manufacture
Current Advisors List
Board_member
2013-01-01
Advisor
Advisor
2012-03-01
Advisor
Current Employees Featured
Thomas wirth CSO @ Aurealis Pharma
CSO
2013-01-01
Founder
Investors List
Finnvera Venture Capital
Finnvera Venture Capital investment in Series B - Aurealis Pharma
Business Finland
Business Finland investment in Series B - Aurealis Pharma
Finnvera Venture Capital
Finnvera Venture Capital investment in Series A - Aurealis Pharma
Business Finland
Business Finland investment in Series A - Aurealis Pharma
Official Site Inspections
http://www.aurealispharma.com
- Host name: aurealistherapeutics.com
- IP address: 206.189.123.63
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Aurealis Pharma"
About - Aurealis Therapeutics
Previously, CEO and co-founder of Aurealis Pharma AG 2013-2020. Prior to that, CEO of Charles River Discovery Services Finland 2009-2012; CEO and co-founder of Cerebricon Ltd 2001 …See details»
Aurealis Pharma - Crunchbase Company Profile
Aurealis Pharma is a biopharmaceutical company aiming at developing ground-breaking medicines for the treatment of cancer and chronic wounds. They are …See details»
Aurealis Pharma Company Profile | Management and Employees …
Aurealis Pharma Profile and History. Aurealis Pharma is a Basel, Switzerland and Kuopio, Finland based privately-held biopharmaceutical company focusing on developing broadly applicable …See details»
Aurealis Therapeutics AG – Swiss Biotech
Aurealis Therapeutics is a Swiss-Nordic Cell and Gene Therapy Platform Company. Our multi-target Bacterial Vector therapy platform, based on genetically modified lactic bacteria, addresses unmet medical needs: Chronic …See details»
Aurealis Pharma - Products, Competitors, Financials, Employees ...
Aurealis Pharma develops cell and gene therapies within the biotechnology sector. Use the CB Insights Platform to explore Aurealis Pharma's full profile. Aurealis Pharma - Products, …See details»
Aurealis Pharma - Overview, News & Similar companies - ZoomInfo
Aurealis Pharma. Manufacturing · Connecticut, United States · 39 Employees. View Company Info for Free . Overview. Headquarters 470 James St Ste 7, New Haven, Connecticut, 065...See details»
Aurealis Pharma Company Profile - Office Locations, Competitors …
Aurealis Pharma has 5 employees across 2 locations and $5.71 m in total funding,. See insights on Aurealis Pharma including office locations, competitors, revenue, financials, executives, …See details»
Aurealis Therapeutics | Multi-target cell and gene …
Aurealis 4-in-1 multi-target cell and gene therapy platform is the game-changing solution for complex multi-factorial diseases. Discover how our technology is re-defining the treatment of chronic wounds (diabetic foot ulcers, venous leg …See details»
Aurealis Therapeutics - Crunchbase Company Profile & Funding
Organization. Aurealis Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Aurealis Therapeutics is a swiss …See details»
Aurealis Pharma Company Information - Funding, Investors, and …
The company Aurealis Pharma has raised a total of $7.73m in funding over 1 rounds. Key Insights: Series B: $7.73m; 2019. Aurealis Pharma Series B (2019, $7M) $7.73m. Similar …See details»
Aurealis Pharma - VentureRadar
Aurealis Pharma is a biopharmaceutical company based in Kuopio, Finland. Thanks to advancements in modern biotechnology and our research and development in cell-based …See details»
Company Information - RocketReach
Aurealis Therapeutics employs 18 employees. The Aurealis Therapeutics management team includes Juha Yrjänheikki (CEO), Mirka Sanio (Clinical Operations Director), and Maija Rusi …See details»
Aurealis Therapeutics - Craft
Aurealis Therapeutics is a company that develops a treatment method for chronic non-healing wounds and other regenerative diseases. Its genetically modified lactic acid bacteria based …See details»
Aurealis Therapeutics is leading the world in developing a new …
Oct 21, 2022 Kuopio-based Aurealis Therapeutics has developed a cell and gene therapy platform with a 4-in-1 effect that helps activate the human immune system against severe …See details»
Aurealis Pharma Ltd. - startup.ch
Aurealis Pharma, a privately-held biopharmaceutical company, has developed a broadly applicable technology platform that enables three-in-one combination therapy in one single …See details»
Investors us | Aurealis Therapeutics
Previously, CEO and co-founder of Aurealis Pharma AG 2013-2020. Prior to that, CEO of Charles River Discovery Services Finland 2009-2012; CEO and co-founder of Cerebricon Ltd 2001 …See details»
Aurealis Pharma - Contacts, Employees, Board Members
Organization. Aurealis Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Aurealis Pharma has 4 board …See details»
Aurealis Pharma AG raises 5.6 million Swiss francs
Aug 28, 2017 Aurealis Pharma AG has closed a 5.6 million Swiss franc financing round. Headquartered in Basel and Finland, the biotechnology company develops medications for …See details»
Aurealis Pharma Corporate Headquarters, Office Locations and
Aurealis Pharma Headquarters and Office Locations. Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit. Button CTA. Aurealis Pharma is headquartered in Basel, …See details»
Pipeline and Science - Aurealis Therapeutics
Lead product: AUP-16. Phase 1 clinical study in Diabetic Foot Ulcer (DFU) patients was completed with excellent results.We received approval for Phase 2 clinical study in DFUs in …See details»